-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Xylem, Raises Price Target to $164

Benzinga·07/29/2026 13:57:34
语音播报
RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $159 to $164.